Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$48.27 - $65.25 $170,682 - $230,724
-3,536 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$59.5 - $67.25 $238 - $269
4 Added 0.11%
3,536 $231,000
Q3 2021

Oct 29, 2021

SELL
$60.19 - $75.29 $3,791 - $4,743
-63 Reduced 1.75%
3,532 $230,000
Q1 2021

May 11, 2021

BUY
$57.98 - $73.08 $41,629 - $52,471
718 Added 24.96%
3,595 $221,000
Q4 2020

Feb 05, 2021

BUY
$62.61 - $71.29 $25,983 - $29,585
415 Added 16.86%
2,877 $205,000
Q3 2020

Oct 30, 2020

BUY
$51.39 - $72.41 $462 - $651
9 Added 0.37%
2,462 $171,000
Q2 2020

Jul 22, 2020

SELL
$39.55 - $54.65 $7,277 - $10,055
-184 Reduced 6.98%
2,453 $130,000
Q1 2020

May 14, 2020

BUY
$34.75 - $45.85 $14,629 - $19,302
421 Added 19.0%
2,637 $106,000
Q4 2019

Feb 10, 2020

BUY
$36.66 - $41.78 $81,238 - $92,584
2,216 New
2,216 $90,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.56B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.